PubMed

(in aggiornamento)

Doria S, de Vuono A, Sanlorenzo R, Irtelli F, Mencacci C. Anti-anxiety efficacy of Sudarshan Kriya Yoga in general anxiety disorder: A multicomponent, yoga based, breath intervention program for patients suffering from generalized anxiety disorder with or without comorbidities. J Affect Disord. 2015 Sep 15;184:310-7. doi: 10.1016/j.jad.2015.06.011. Epub 2015 Jun 24. PubMed PMID:26142611.

Degli Esposti L, Sangiorgi D, Mencacci C, Spina E, Pasina C, Alacqua M, la Tour F. Pharmaco-utilisation and related costs of drugs used to treat schizophrenia and bipolar disorder in Italy: the IBIS study. BMC Psychiatry. 2014 Oct 14;14:282. doi: 10.1186/s12888-014-0282-z. PubMed PMID: 25312446; PubMed Central PMCID: PMC4203906.

Aguglia E, Biggio G, Signorelli MS, Mencacci C; Steering Committee on behalf of the STIMA-D Investigators. Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): a nationwide snapshot of the status of treatment for major depression. Pharmacopsychiatry. 2014 May;47(3):105-10. doi:10.1055/s-0034-1375628. Epub 2014 May 20. PubMed PMID: 24846085.

Colombo GL, Agabiti-Rosei E, Margonato A, Mencacci C, Montecucco CM, Trevisan Off-patent generic medicines vs. off-patent brand medicines for six reference drugs: a retrospective claims data study from five local healthcare units in the Lombardy Region of Italy. PLoS One. 2013 Dec 18;8(12):e82990. doi:10.1371/journal.pone.0082990. eCollection 2013. PubMed PMID: 24367576; PubMed Central PMCID: PMC3867455.

Mencacci C, Aguglia E, Biggio G, Cappellari L, Di Sciascio G, Fagiolini A, Maina G, Tortorella A, Katz P, Ripellino C. C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia. Clinicoecon Outcomes Res. 2013 Dec 3;5:611-21. doi: 10.2147/CEOR.S52063. eCollection 2013. PubMed PMID:24348057; PubMed Central PMCID: PMC3857011.

Mencacci C, Aguglia E, Biggio G, Cappellari L, Di Sciascio G, Fagiolini A, Maina G, Tortorella A, Katz P, Ripellino C. C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants in major depressive disorder in Italy. Adv Ther. 2013 Jul;30(7):697-712. doi: 10.1007/s12325-013-0046-z. Epub 2013 Aug 9. PubMed PMID: 23929174.

Cortesi PA, Mencacci C, Luigi F, Pirfo E, Berto P, Sturkenboom MC, Lopes FL, Giustra MG, Mantovani LG, Scalone L. Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study. BMC Psychiatry. 2013 Mar 22;13:98. doi: 10.1186/1471-244X-13-98. PubMed PMID: 23522406; PubMed Central PMCID: PMC3621844.

Mencacci C, Di Sciascio G, Katz P, Ripellino C. Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy. Clinicoecon Outcomes Res. 2013;5:87-99. doi: 10.2147/CEOR.S39492. Epub 2013 Feb 7. PubMed PMID: 23413176; PubMed Central PMCID: PMC3570079.

Perugi G, Fornaro M, Maremmani I, Canonico PL, Carbonatto P, Mencacci C, Muscettola G, Pani L, Torta R, Vampini C, Parazzini F, Dumitriu A, Angst J; Come To Me Study Group. Discriminative hypomania checklist-32 factors in unipolar and bipolar major depressive patients. Psychopathology. 2012;45(6):390-8. doi: 10.1159/000338047. Epub 2012 Aug 7. PubMed PMID: 22890230.

Mencacci C; All Investigators. Efficacy and tolerability of switching to ziprasidone in italian patients with acute exacerbation of schizophrenia: an open-label trial. Pharmacopsychiatry. 2012 Sep;45(6):236-40. Epub 2012 May 16. PubMed PMID: 22592506.

Maremmani I, Perugi G, Rovai L, Maremmani AG, Pacini M, Canonico PL, Carbonato P, Mencacci C, Muscettola G, Pani L, Torta R, Vampini C, Akiskal HS. Are “social drugs” (tobacco, coffee and chocolate) related to the bipolar spectrum? J Affect Disord. 2011 Sep;133(1-2):227-33. doi: 10.1016/j.jad.2011.04.019. Epub 2011 May 24. PubMed PMID: 21605911.

Fornaro M, Maremmani I, Canonico PL, Carbonatto P, Mencacci C, Muscettola G, Pani L, Torta R, Vampini C, Parazzini F, Dumitriu A, Perugi G. Prevalence and diagnostic distribution of medically unexplained painful somatic symptoms across 571 major depressed outpatients. Neuropsychiatr Dis Treat. 2011;7:217-21. doi: 10.2147/NDT.S17949. Epub 2011 Apr 21. PubMed PMID: 21573083; PubMed Central PMCID: PMC3090285.

Nasso ED, Chiesa A, Serretti A, De Ronchi D, Mencacci C. Clinical and demographic predictors of improvement during duloxetine treatment in patients with major depression: an open-label study. Clin Drug Investig. 2011;31(6):385-405. doi: 10.2165/11588800-000000000-00000. PubMed PMID: 21366360.

Lurati C, Riva M, Resega R, Mantica C, Garassino MC, Sburlati P, La Verde N, Cinquini M, Piva S, Mencacci C, Farina G. A mono-institutional prospective study on the effectiveness of a specialist psychotherapeutic intervention (POI) started at the diagnosis of cancer. Support Care Cancer. 2012 Mar;20(3):475-81. doi: 10.1007/s00520-011-1096-x. Epub 2011 Jan 22. PubMed PMID: 21258946.

Perugi G, Canonico PL, Carbonato P, Mencacci C, Muscettola G, Pani L, Torta R, Vampini C, Fornaro M, Parazzini F, Dumitriu A; Come To Me Study Group. Unexplained somatic symptoms during major depression: prevalence and clinical impact in a national sample of Italian psychiatric outpatients. Psychopathology. 2011;44(2):116-24. doi: 10.1159/000319848. Epub 2011 Jan 12. PubMed PMID: 21228616.

Hale A, Corral RM, Mencacci C, Ruiz JS, Severo CA, Gentil V. Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study. Int Clin Psychopharmacol. 2010 Nov;25(6):305-14. doi: 10.1097/YIC.0b013e32833a86aa. PubMed PMID: 20856123.

Volonteri LS, Cerveri G, De Gaspari IF, Baldi ML, Rolandi ML, Papa P, Mauri MC, Mencacci C. Long-acting injectable risperidone and metabolic ratio: a possible index of clinical outcome in treatment-resistant schizophrenic patients. Psychopharmacology (Berl). 2010 Jul;210(4):489-97. doi: 10.1007/s00213-010-1852-5. Epub 2010 Apr 27. PubMed PMID: 20422405.

De Candia MP, Di Sciascio G, Durbano F, Mencacci C, Rubiera M, Aguglia E, Garavini A, Bersani G, Di Sotto A, Placidi G, Cesana BM. Effects of treatment with etizolam 0.5 mg BID on cognitive performance: a 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder. Clin Ther. 2009 Dec;31(12):2851-9. doi: 10.1016/j.clinthera.2009.12.010. PubMed PMID: 20110024.

Volonteri LS, Colasanti A, Cerveri G, Fiorentini A, De Gaspari IF, Mauri MC, Valli A, Papa P, Mencacci C. Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels. J Psychopharmacol. 2010 Aug;24(8):1193-9. doi: 10.1177/0269881109104863. Epub 2009 Apr 30. PubMed PMID: 19406851.

Genazzani A, Gambacciani M, Simoncini T, Anniverno R, Becorpi AM, Biglia N, Brandi ML, Guaschino S, Lello S, Massobrio M, Melis GB, Mencacci C, Modena MG, Nappi C, Nappi RE, Pecorelli S, Petraglia F, Rosano GM, Serra GB, Sismondi P, Taddei S, Tonelli F. Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007. Gynecol Endocrinol. 2007;23(8):436-44. PubMed PMID: 17934930.

Durbano F, Mencacci C, Dorigo D, Riva M, Buffa G. The long-term efficacy and tolerability of carbolithium once a day: an interim analysis at 6 months. Clin Ter. 2002 May-Jun;153(3):161-6. PubMed PMID: 12161976.

Maremmani I, Perugi G. Rovai L ….Mencacci C “ Are “social drugs” (tobacco,coffee and chocolate)related to the bipolar spectrum” Journal Affective Disorders 133 (2011)

FattoriA, Neri L.Aguglia E. Bellomo A….Mencacci C “Estimating the impact of workplace Bullying:Humanistic and economics Burden among Workers with chronic Medical Conditions” Biomed Research International Hindawi Publishing Corporations 2015-10-26

Mencacci C, Ullo A. Larcan R, Orthmann N. Merzagora F.Aguglia E. “ Genere e disturbi del sonno. Studio multicentrico e ricerca qualitativa nella popolazione italiana” Journal of Psychopathology Vol 19 dicembre 2013

Mencacci C et All “ Efficay and tolerability of switching to ziprasidone in italian with acute exacerbation of schizophrenia : an open label trial” Pharmacopsychiatry 2012 Sep;45